Document is current
Any future updates will be listed below
-
Authors
Gamble, Samuel
Whiteman, Zoe E.
Peinador-Marín, Claudia https://orcid.org/0009-0003-9791-1176
Lebrusant-Fernandez, Marta
Shurr, Abigail Y. L. https://orcid.org/0009-0002-6069-5871
Enica, Andrei https://orcid.org/0000-0001-8117-2207
Sahwangarrom, Teerapon
Ung, Seng Kuong Anakin
Rogers, Amber https://orcid.org/0000-0002-7071-7889
Fessas, Petros
Khaw, Chuen Ryan
Kalinke, Lukas
Ahlmann-Eltze, Constantin
Alhendi, Ahmed S. N. https://orcid.org/0000-0002-1883-2142
Otter, Kate
Hu, Xiuchuan
Thakkar, Krupa
Gration, Betty
Newsham, Izzy https://orcid.org/0000-0003-0816-4045
Uddin, Imran https://orcid.org/0000-0003-0736-3149
Musson, Ellen Nuttall https://orcid.org/0000-0002-0395-3304
Lazarus, Kyren A.
Przybilla, Moritz J. https://orcid.org/0000-0001-5645-9492
Pennycuick, Adam
Hall, Helen
Hagel, Zoe
Percival, Charlotte
Prendecki, Ruth
Tisi, Sophie
Constantinou, Georgia
Durrenberger, Pascal F.
,
Gowers, Kate H. C.
Wong, Yien Ning Sophia
Linch, Mark
Litchfield, Kevin https://orcid.org/0000-0002-3725-0914
Payne, Elspeth M. https://orcid.org/0000-0001-5841-778X
Lee, Se-Hoon https://orcid.org/0000-0002-9219-3350
Quezada, Sergio A. https://orcid.org/0000-0002-9763-1700
Campbell, Peter J. https://orcid.org/0000-0002-3921-0510
Beane, Jennifer E. https://orcid.org/0000-0002-6699-2132
Mazzilli, Sarah A.
Moore, David A. https://orcid.org/0000-0002-6296-1312
Teixeira, Vitor H. https://orcid.org/0000-0003-0090-861X
Gómez-López, Sandra https://orcid.org/0000-0001-5163-6066
Vanhaesebroeck, Bart https://orcid.org/0000-0002-7074-3673
Janes, Sam M. https://orcid.org/0000-0002-6634-5939
Reading, James L. https://orcid.org/0000-0001-5381-978X
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 20 August 2026
First Online: 7 October 2026
Ethics
Competing interests: J.L.R. reports speaker fees from Boehringer Ingelheim and GlaxoSmithKline. J.L.R. and S.M.J. have filed patents for cancer early detection (PCT/EP2023/076521 and PCT/EP2023/076511), on which S.G., C.P.-M., and V.H.T. are co-inventors. B.V. is a consultant for iOnctura (Geneva, Switzerland), a shareholder of Open Orphan and Poolbeg and a director of S&B Scientific. S.M.J. has received fees for advisory board membership in the past 3 years from Bard1 Lifescience. He has received grant income from GRAIL. He is an unpaid member of a GRAIL advisory board. He has received lecture fees for academic meetings from Chiesi and AstraZeneca. His wife worked for Astra Zeneca. The other authors declare no competing interests.
